Vor Biopharma

VOR

Börsenwert 1,23 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 RA Capital Management Boston, Massachusetts	55,3 Mio. $	–	–	–
2	2 5AM Venture Management San Francisco, California	31,6 Mio. $	–	–	–
3	3 Fidelity Investments Boston, Massachusetts	15,8 Mio. $	+512 $	+5	+0 %
4	4 Paradigm Biocapital Advisors New York	6,48 Mio. $	+2,1 Mio. $	+20.495	+46 %
5	BBA 5 Baker Bros. Advisors New York	5,66 Mio. $	+5,83 Mio. $	+56.938	Neu
6	6 Woodline Partners San Francisco, California	5,52 Mio. $	–	–	–
7	7 Johnson & Johnson New Brunswick, New Jersey	5,34 Mio. $	–	–	–
8	8 Laurion Capital Management New York	4,26 Mio. $	–	–	–
9	9 OrbiMed New York	4,14 Mio. $	–	–	–
10	10 Vanguard Group Malvern, Pennsylvania	3,27 Mio. $	-16.889 $	-165	-0,5 %
11	11 Sarissa Capital Management Greenwich, Connecticut	3,07 Mio. $	-455.581 $	-4.451	-13 %
12	AG 12 Artal Group Luxembourg	2,73 Mio. $	–	–	–
13	13 BlackRock New York	2,19 Mio. $	-4,65 Mio. $	-45.456	-67 %
14	14 OUP Management Company Bala Cynwyd, Pennsylvania	1,86 Mio. $	–	–	–
15	15 Millennium Management New York	1,44 Mio. $	+1,39 Mio. $	+13.616	+1.639 %
16	16 Thrivent Financial for Lutherans Minneapolis, Minnesota	1,43 Mio. $	-97.032 $	-948	-6 %
17	17 JP Morgan Chase New York	852.000 $	-60.389 $	-590	-6 %
18	18 Geode Capital Management Boston, Massachusetts	533.000 $	-765.716 $	-7.481	-58 %
19	E 19 Ergoteles New York	430.000 $	+360.391 $	+3.521	+440 %
20	20 Citadel Advisors Miami, Florida	394.000 $	+111.464 $	+1.089	+38 %
21	21 Bridgeway Capital Management Houston, Texas	345.000 $	+355.171 $	+3.470	Neu
22	BG 22 Bollard Group Boston, Massachusetts	276.000 $	–	–	–
23	23 Susquehanna International Group Bala Cynwyd, Pennsylvania	264.000 $	+271.650 $	+2.654	Neu
24	24 Charles Schwab San Francisco, California	207.000 $	-266.634 $	-2.605	-56 %
25	25 State Street Boston, Massachusetts	205.000 $	-1,24 Mio. $	-12.093	-85 %

Vor Biopharma VOR Börsenwert 1,23 Mrd. $

Vor Biopharma

VOR

Börsenwert 1,23 Mrd. $